4//SEC Filing
Stankovic Srdjan R. 4
Accession 0001209191-21-066570
CIK 0001070494other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 6:00 PM ET
Size
8.8 KB
Accession
0001209191-21-066570
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2021-11-19+6,250→ 44,315 total - Sale
Common Stock
2021-11-22$19.01/sh−2,803$53,285→ 41,512 total - Exercise/Conversion
Restricted Stock Units
2021-11-19−6,250→ 6,250 total→ Common Stock (6,250 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The restricted stock units vest in four equal annual installments beginning 11/19/2019.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001432545
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 6:00 PM ET
- Size
- 8.8 KB